STAR Protocols (Jun 2024)

Protocol for enrichment and functional analysis of human hematopoietic cells from umbilical cord blood

  • Sarah Gutch,
  • Lindsay Beasley,
  • Scott Cooper,
  • Mark H. Kaplan,
  • Maegan L. Capitano,
  • James Ropa

Journal volume & issue
Vol. 5, no. 2
p. 103024

Abstract

Read online

Summary: Umbilical cord blood (CB) is a donor source for hematopoietic cell therapies. Understanding what drives hematopoietic stem and progenitor cell function is critical to our understanding of the usage of CB in hematopoietic cell therapies. Here, we describe how to isolate and analyze the function of human hematopoietic cells from umbilical CB. This protocol demonstrates assays that measure phenotypic properties and hematopoietic cell potency.For complete details on the use and execution of this protocol, please refer to Broxmeyer et al.1 : Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.

Keywords